Please login to the form below
UCB
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.
HTA guidance from NICE, the SMC and the AWMSG
Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group
Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis
Amgen and UCB’s Evenity (romosozumab) has been recommended for use by the NHS in England and Wales by the National Institute for Health and Care Excellence (NICE). ... manager, UCB UK and Ireland.
CBI launches new Health Council as part of its Seize The Moment 2030 vision
IBM, Imperial College University, J&J, John Lewis Partnership, Novo Nordisk, Prenetics, Pure Gym, Roche, UCB, University of Birmingham, University of Edinburgh, Vanguard Solutions, Vitality, Pfizer, Imperial College University, Johnson &Johnson
AbbVie acquires Syndesi Therapeutics in $1bn deal
The acquisition further reinforces AbbVie’s neurology pipeline, as four years ago, Syndesi Therapeutics gained the rights to UCB’s synaptic vesicle protein 2A (SV2A) programme, which aims to achieve synaptic
Advantage Hers - Empowering Women with Chronic Inflammatory Diseases
by Ruder Finn for UCB Biopharma. Like millions of women around the world with chronic disease, world renowned tennis champion Caroline Wozniacki struggled with receiving a timely diagnosis and effective support ... Advantage Hers - Empowering Women with
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Scientists discover new approach to treat brain tumours
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC
- Roche’s Polivy receives EC approval for lymphoma therapy
- Eli Lilly announces $2.1bn investment in new manufacturing sites
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- A Medscape Oncology exclusive preview
- What does the future hold for clinical trial recruitment?
- Roche shares new positive Ocrevus data for MS patients
- Almirall and Evotec team up in multi-target dermatology alliance
- Evolve, evolve, evolve; a call to action to all leaders in the healthcare industry
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- First Herceptin biosimilar cleared in Europe
- India denies Vertex patent on cystic fibrosis drug Orkambi
PMHub
Genesis Research
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...
Latest intelligence
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
- What does the future hold for clinical trial recruitment?
- The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
